NEWARK, Del, May 04, 2023 (GLOBE NEWSWIRE) -- The pharmaceutical lipids market is anticipated to expand its roots at an average CAGR of 5.0% between 2023 and 2033. The market is projected to have a market share of US$ 8.04 Billion by 2033 while it is likely to be valued at US$ 4.93 Billion in 2023.
- The expanding pharmaceutical industry along with the application in the cosmetics industry is flourishing the market growth. Furthermore, the cosmetic usage of emulsifiers, ointments, and creams is fueling the demand for pharmaceutical lipids.
- The collaboration and mergers between pharmaceutical brands and lipid suppliers are reshaping the market. Furthermore, the local drug supplies are attributed to the market growth.
- The high demand for drugs along with the rising number of diseases such as cancer, and others are penetrating the market dynamics. The lipid-based drugs with long-shelf life are also propelling the market.
- There is an increase in government investment in the health sector and research and development facilities for lipid integration. Furthermore, the effective application of blended essential oil and increased demand for triglycerides are garnering market growth.
- The lipids deliver vitamins A, D, E, and K along with the introduction of biological processes introducing new products.
Drivers and Challenges have an Impact on Market Dynamics, which can Impact Businesses. Get your Sample Report now: https://www.futuremarketinsights.com/reports/sample/rep-gb-10983
Key Points:
- The United States market leads the pharmaceutical lipids market in terms of market share in North America. The United States region held a market share of 26.1% by 2022. The growth in this region is attributed to expanding pharmaceutical industry, advanced research and development. North American market held a market share of 27.6% in 2022, putting it as a leading region in terms of market share.
- The United Kingdom’s pharmaceutical lipids market is another significant market in Europe region. The market thrives at a CAGR of 4.70% between 2023 and 2033. The growth is attributed to high drug delivery, better drug formation, and expanding clinical trials are thriving the market growth.
- India pharmaceutical lipids market thrives at a CAGR of 5.0% during the forecast period. The growth is attributed to the country being the world’s pharmacy during the forecast period.
- The triglycerides lead the product type segment as it held a market share of 45.3% in 2022. The growth is due to its fatty acid elements being used in cosmetics.
- Based on the source type, the semi-synthetic segment leads as it held a market share of 48.1% in 2022.
Competitive Landscape:
The key vendors work on the integration of essential oils and lipids to produce effective lipid medicines. Key competitors merge, acquire, and partner with other companies to increase their supply chain and distribution channel.
Recent Market Developments:
- Dishman Group is introducing its chemspec Europe 2023, which is an exhibition for fine and specialty chemicals. The event is likely to take place in Basel, Switzerland.
- Cayman Chemical Company has introduced its list of lipid contents with its different uses in biology and health & disease. These lipids include structural lipids, bioactive lipids, lipids in cancer, skin barrier, and lipids in covid-19
Are you looking for more details about the latest trends, drivers, and challenges? Speak with our Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-10983
Key Players:
- ABITEC Corporation (ABF Ingredients)
- BASF SE
- Croda International Plc
- CordenPharma
- NOF (Nippon Oil & Fats) Corporation
- Cayman Chemical Company
- Lipoid GmbH
- Nippon Fine Chemical Co. Ltd.
- Dishman Group
- Gattefossé
- IOI Oleo GmbH
- Stepan Company
- Evonik Industries AG
Market Segmentation:
By Product:
- Triglycerides
- Phospholipids
- Sphingolipids
- Cholesterol
- Fatty Acids
- Others
By Source:
- Synthetic
- Semi-synthetic
- Natural
By Form:
- Liquid
- Semi-solid
- Solid
By Application:
- Conventional Lipid-based Drug Delivery Systems
- Self-Emulsifying Drug Delivery Systems
- Self-Microemulsifying Drug Delivery Systems
- Liposomes
- Solid Lipid Nanoparticles
- Nanostructured Lipid Carriers
- Others
By Route of Administration:
- Oral
- Tablet
- Solution
- Parenteral
- Intravenous
- Intramuscular (Vaccines)
- Topical
Buy Now and Gain Access to Identify Key Trends, Drivers, and Challenges in the Market @ https://www.futuremarketinsights.com/checkout/10983
Table of Content (ToC):
1. Executive Summary | Pharmaceutical Lipids Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
Have a Look at Related Research Reports in the Healthcare Domain:
Pharmaceutical Sterility Testing Market Growth: The pharmaceutical sterility testing market is anticipated to be generated global sales revenue of US$ 1,250.7 Million in 2023. Demand is expected to develop at a CAGR of 11.8% to reach a valuation of US$ 3,815.6 Million by 2033.
Bacteriophage Market Trend: The bacteriophage market is capturing a valuation of US$ 45.07 Million in 2023 and is predicted to reach US$ 68 Million by 2033. The market is likely to register a CAGR of 4.2% during the forecast period.
Fecal Pancreatic Elastase Testing Market Outlook: The fecal pancreatic elastase testing market is expected to increase from US$ 15,306.7 Million in 2023 to US$ 31,842.3 Million by 2033. The market is likely to capture a 7.6% CAGR from 2023 to 2033.
Nasal Allergy Treatment Market Forecast: The global nasal allergy treatment market enjoys a valuation of US$ 6.6 Billion in 2022, and it is further projected to expand at a CAGR of 6.7% over the forecasted years.
Venous Stents Market Analysis: The global venous stents market held a valuation of US$ 921.4 Million in 2022, and it is anticipated to expand at a CAGR of 8.4% over the forecasted years.
IoT in Healthcare Market Size: The global IoT in healthcare market is projected to reach US$ 181.4 Billion in 2022, anticipated to grow at a CAGR of 18.0%, reaching US$ 952.3 Billion by 2032.
Pancreatic Stone Protein Testing Market Value: The pancreatic stone protein testing market is likely to record a strong CAGR of 1.8% during the forecast period. The pancreatic stone protein testing market is currently valued at US$ 3 Billion in 2022 and is likely to reach US$ 3.59 Billion by 2032.
Multiple Unit Pellet Systems Market Sales: The global multiple unit pellet systems (MUPS) market was valued at US$ 3.48 Billion in the year 2021, expanding at a CAGR of 3.5% to reach ~US$ 5.07 Billion by the end of 2032.
Humeral Implants Market Volume: The global humeral implants market is likely to be valued at US$ 963.8 Million in 2022. From 2022 to 2032, sales of humeral implants are expected to flourish at a 7.1% CAGR, reaching US$ 2,106 Million.
Complex Regional Pain Syndrome (CRPS) Market Demand: The global market for complex regional pain syndrome (CRPS) is estimated to be worth US$ 101.9 Million in 2022, rising to US$ 126.7 Million by 2032.
About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.
Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
LinkedIn | Twitter | Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com
